DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/j364vc/ion_channel) has announced the addition of the "Ion Channel Modulators - Global Strategic Business Report" report to their offering.
Increased Interest Witnessed in Outsourcing of Ion Channel Services
This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2018. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 47 companies including many key and niche players such as:
- Bayer HealthCare
- CalciMedica, Inc.
- Convergence Pharmaceuticals Limited
- Evotec AG
Key Topics Covered
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. EXECUTIVE SUMMARY
- Industry Overview
- Ion Channel Modulators By Therapeutic Indication
- Market Dynamics
- Product Overview
- Recent Industry Activity
- Focus On Select Global Players
- Global Market Perspective
- The United States
- Latin America
- Rest Of World
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 47 (including Divisions/Subsidiaries - 50)
The United States (20)
- France (2)
- Germany (6)
- The United Kingdom (6)
- Italy (2)
- Rest of Europe (10)
Asia-Pacific (Excluding Japan) (1)
For more information visit http://www.researchandmarkets.com/research/j364vc/ion_channel